All Eyes On Pfizer For More Details On COVID-19 Vaccine Launch
Executive Summary
Pfizer's COVID-19 vaccine is sure to dominate the third quarter results call, with everything from data to widescale distribution and the potential financial reward on the minds of investors and the public.